Latest Breaking News On - Neuwittelsbach hospital - Page 1 : comparemela.com

Patients with rheumatic disease treated with biosimilar SDZ ETN reported high treatment persistence at month 12 as well as comparable safety and efficacy.

Docus herbert kellnerHerbert kellnerDepartment of rheumatologyNeuwittelsbach hospitalDisease activity scoreErythrocyte sedimentation rate